The Centers for Medicare & Medicaid Services will not cover drugs when exclusively used for weight loss, like Ozempic or ...

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage ...

The Trump administration has chosen not to finalize a rule proposed by the Biden administration that would have allowed ...

President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the ...

The Biden administration proposal would have significantly expanded access to obesity to millions of Americans but would have cost the government billions.

The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.

It seems like everyone and their sister is taking a GLP-1 (“glucagon-like peptide-1 receptor agonists,” if you’re feeling nasty), or is at least thinking about it. These meds—which include Ozempic, ...